Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Authors:
Open Access
- 23 October 2018
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 29 (suppl_8) , viii713